Shukra Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	18,496	9,568	3,575	514	95	70
Market Cap Growth	88.07%	167.65%	595.01%	443.89%	35.73%	-4.81%
Enterprise Value	18,400	9,415	3,504	520	199	165
Last Close Price	42.24	21.84	8.03	1.15	0.31	0.23
PE Ratio	106.52	99.92	19.28	11.67	12.60	37.04
PS Ratio	28.65	29.36	4.79	0.87	0.46	0.62
PB Ratio	28.11	15.23	6.20	2.03	0.58	0.45
P/TBV Ratio	28.11	15.23	6.20	2.03	0.58	0.45
P/FCF Ratio	-	184.87	-	-	1.47	-
P/OCF Ratio	-	120.83	-	16.23	1.18	12.97
EV/Sales Ratio	28.50	28.89	4.70	0.88	0.97	1.47
EV/EBITDA Ratio	46.79	60.91	16.18	8.01	6.78	9.38
EV/EBIT Ratio	51.68	75.61	17.87	11.17	15.63	58.82
EV/FCF Ratio	-	181.91	-	-	3.09	-
Debt / Equity Ratio	0.06	0.07	0.06	0.20	0.21	0.63
Debt / EBITDA Ratio	0.10	0.27	0.15	0.78	1.15	5.57
Debt / FCF Ratio	-	0.81	-	-	0.52	-
Asset Turnover	-	0.40	0.98	1.08	0.58	0.32
Inventory Turnover	-	1.35	16.28	12.78	3.73	1.81
Quick Ratio	-	2.33	2.89	1.00	0.62	1.46
Current Ratio	-	3.79	3.97	1.25	1.28	2.28
Return on Equity (ROE)	-	15.90%	44.70%	21.16%	4.70%	1.21%
Return on Assets (ROA)	-	9.46%	16.04%	5.29%	2.25%	0.51%
Return on Invested Capital (ROIC)	51.34%	16.91%	47.35%	20.16%	4.24%	1.16%
Return on Capital Employed (ROCE)	-	17.90%	30.80%	14.40%	5.60%	1.00%
Earnings Yield	1.58%	1.00%	5.19%	8.57%	7.94%	2.70%
FCF Yield	-	0.54%	-1.95%	-2.57%	68.08%	-18.00%
Dividend Yield	0.02%	0.05%	1.24%	1.09%	4.06%	-
Payout Ratio	-	45.73%	0.38%	1.65%	-	-
Buyback Yield / Dilution	-68.39%	-	-551.03%	-7.38%	-	-0.02%
Total Shareholder Return	-68.37%	0.05%	-549.78%	-6.29%	4.06%	-0.02%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.